FTC

Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up
Watch out, Allergan. Activist investor David Tepper won approval to push a shake-up
Fierce Pharma
investors
Allergan
David Tepper
FTC
Flag link:
The FTC Appeals Shire ViroPharma Dismissal
The FTC Appeals Shire ViroPharma Dismissal
FDA Law Blog
FTC
Shire
ViroPharma
Hatch Waxman Act
Flag link:
Court Dismisses FTC’s Citizen Petition Complaint Against Shire
Court Dismisses FTC’s Citizen Petition Complaint Against Shire
RAPS.org
FTC
citizen petitions
Shire
ViroPharma
Flag link:
FDA chief to big pharma: ‘End the shenanigans’
FDA chief to big pharma: ‘End the shenanigans’
Drug Delivery Business News
FDA
Scott Gottlieb
FTC
generics
competition
Flag link:
Pay-for-Delay Deals: FTC Notes Continued Decline Since SCOTUS Ruling
Pay-for-Delay Deals: FTC Notes Continued Decline Since SCOTUS Ruling
RAPS.org
FTC
pay-for-delay
Supreme Court
Flag link:
How Far Into the Drug Pipeline Should the FTC Reach?
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
Flag link:
Pharmaceutical Industry Cannibalization: The Launch of Authorized Generics After the Loss of Market Exclusivity
Pharmaceutical Industry Cannibalization: The Launch of Authorized Generics After the Loss of Market Exclusivity
Xtalks
generics
FDA
FTC
market exclusivity
Flag link:
Mylan hit with antitrust lawsuit over EpiPen device
Mylan hit with antitrust lawsuit over EpiPen device
Mass Device
Mylan Labs
antitrust
EpiPens
drug pricing
FTC
Flag link:
FTC, Endo propose agreement to resolve pay-for-delay dispute
FTC, Endo propose agreement to resolve pay-for-delay dispute
Bizjournals.com
FTC
Endo International
pay-for-delay
Opana ER
lidoderm
Flag link:
FTC is ‘aware’ of concerns over possible Mylan antitrust violations
FTC is ‘aware’ of concerns over possible Mylan antitrust violations
Stat/Pharmalot
FTC
Mylan Labs
antitrust
Flag link:
FTC Clears Teva Pharmaceutical Industries-Allergan plc Generics Deal; What's Next?
FTC Clears Teva Pharmaceutical Industries-Allergan plc Generics Deal; What's Next?
Bidness, ETC
FTC
Teva Pharmaceuticals
Allergan
generics
Flag link:
Teva will provide long-term API contracts to producers in 15 markets
Teva will provide long-term API contracts to producers in 15 markets
BioPharma Dive
Teva Pharmaceutical
APIs
drug manufacturing
FTC
Flag link:
FTC seeks more info on Abbott-St. Jude deal
FTC seeks more info on Abbott-St. Jude deal
Yahoo/Reuters
FTC
devices
Abbott Labs
St. Jude Medical
M&A
Flag link:
Treasury Department Was 'Targeting' Pfizer-Allergan Deal
Treasury Department Was 'Targeting' Pfizer-Allergan Deal
TheStreet.com
US Treasury Department
FTC
Pfizer
Allergan
M&A
Flag link:
What's Allergan's Biggest Risk Now?
What's Allergan's Biggest Risk Now?
Motley Fool
Allergan
Pfizer
M&A
FTC
generics
drug pricing
Flag link:
Allergan Broke Antitrust Laws With Endo Drug Deal, U.S. Says
Allergan Broke Antitrust Laws With Endo Drug Deal, U.S. Says
Bloomberg
Allergan
antitrust
Endo International
FTC
Flag link:
FTC Can Derail Pfizer-Allergan Merger in More Ways Than One
FTC Can Derail Pfizer-Allergan Merger in More Ways Than One
Bidness, ETC
FTC
Pfizer
Allergan
M&A
Flag link:
Teva's $40.5 billion generics deal with Allergan hits FTC snag
Teva's $40.5 billion generics deal with Allergan hits FTC snag
BioPharma Dive
Teva Pharmaceutical
Allergan
generics
FTC
M&A
Flag link:
Another Court Weighs In on Whether Off-Label Promotion is Per Se Illegal; Jury Finds Both Defendants Not Guilty on All Counts
Another Court Weighs In on Whether Off-Label Promotion is Per Se Illegal; Jury Finds Both Defendants Not Guilty on All Counts
FDA Law Blog
FDA
off-label
FTC
devices
free speech
Flag link:
FTC Releases Latest Staff Report on Drug Patent Settlement Agreements; Post-Actavis Trends Seem to Be Forming
FTC Releases Latest Staff Report on Drug Patent Settlement Agreements; Post-Actavis Trends Seem to Be Forming
FDA Law Blog
FTC
patents
Actavis
pay-for-delay
Flag link:

Pages